Intra-Cellular Therapies (ITCI) PT Raised to $96 at Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of Hormuz reopening
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Form 8-K Intra-Cellular Therapies For: Apr 17
April 18, 2024 5:26 PM EDTfalse 0001567514 0001567514 2024-04-17 2024-04-17... More
Form 424B5 Intra-Cellular Therapies
April 18, 2024 5:24 PM EDTTable of Contents
Filed pursuant to Rule 424(b)(5)
Registration No. 333-278726
Prospectus supplement
(To prospectus dated April 16, 2024)
... More